Nirmatrelvir-ritonavir for COVID-19. 2022

Emily G McDonald, and Todd C Lee
Clinical Practice Assessment Unit (McDonald, Lee), and Divisions of Internal Medicine (McDonald) and Infectious Diseases (Lee), Department of Medicine, McGill University Health Centre, Montréal, Que. emily.mcdonald@mcgill.ca.

UI MeSH Term Description Entries
D007769 Lactams Cyclic AMIDES formed from aminocarboxylic acids by the elimination of water. Lactims are the enol forms of lactams. Lactam,Lactim,Lactims
D007930 Leucine An essential branched-chain amino acid important for hemoglobin formation. L-Leucine,Leucine, L-Isomer,L-Isomer Leucine,Leucine, L Isomer
D009570 Nitriles Organic compounds containing the -CN radical. The concept is distinguished from CYANIDES, which denotes inorganic salts of HYDROGEN CYANIDE. Nitrile
D011392 Proline A non-essential amino acid that is synthesized from GLUTAMIC ACID. It is an essential component of COLLAGEN and is important for proper functioning of joints and tendons. L-Proline,L Proline
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000084762 Viral Protease Inhibitors Compounds that specifically inhibit PROTEOLYTIC ENZYMES that are encoded by VIRUSES. Inhibitor of Viral Protease,Virus Protease Inhibitors,Inhibitors, Viral Protease,Inhibitors, Virus Protease,Protease Inhibitor, Viral,Protease Inhibitors, Viral,Protease Inhibitors, Virus,Viral Protease Inhibitor
D000086402 SARS-CoV-2 A species of BETACORONAVIRUS causing atypical respiratory disease (COVID-19) in humans. The organism was first identified in 2019 in Wuhan, China. The natural host is the Chinese intermediate horseshoe bat, RHINOLOPHUS affinis. 2019 Novel Coronavirus,COVID-19 Virus,COVID19 Virus,Coronavirus Disease 2019 Virus,SARS Coronavirus 2,SARS-CoV-2 Virus,Severe Acute Respiratory Syndrome Coronavirus 2,Wuhan Coronavirus,Wuhan Seafood Market Pneumonia Virus,2019-nCoV,2019 Novel Coronaviruses,COVID 19 Virus,COVID-19 Viruses,COVID19 Viruses,Coronavirus 2, SARS,Coronavirus, 2019 Novel,Coronavirus, Wuhan,Novel Coronavirus, 2019,SARS CoV 2 Virus,SARS-CoV-2 Viruses,Virus, COVID-19,Virus, COVID19,Virus, SARS-CoV-2,Viruses, COVID19
D000093485 COVID-19 Drug Treatment The use of DRUGS to treat COVID19 or its symptoms. COVID-19 Drug Therapy,COVID19 Drug Therapy,COVID19 Drug Treatment,Coronavirus Disease 2019 Drug Treatment,Coronavirus Disease-19 Drug Treatment,COVID 19 Drug Therapy,COVID 19 Drug Treatment,COVID-19 Drug Therapies,COVID19 Drug Therapies,COVID19 Drug Treatments,Coronavirus Disease 19 Drug Treatment,Drug Therapy, COVID-19,Drug Therapy, COVID19,Therapy, COVID-19 Drug,Therapy, COVID19 Drug,Treatment, COVID-19 Drug

Related Publications

Emily G McDonald, and Todd C Lee
April 2022, Australian prescriber,
Emily G McDonald, and Todd C Lee
January 2023, Frontiers in pharmacology,
Emily G McDonald, and Todd C Lee
August 2022, Clinical journal of the American Society of Nephrology : CJASN,
Emily G McDonald, and Todd C Lee
June 2022, Actualites pharmaceutiques,
Emily G McDonald, and Todd C Lee
September 2022, The Cochrane database of systematic reviews,
Emily G McDonald, and Todd C Lee
November 2023, The Cochrane database of systematic reviews,
Emily G McDonald, and Todd C Lee
December 2023, The Journal of antimicrobial chemotherapy,
Emily G McDonald, and Todd C Lee
June 2023, The New England journal of medicine,
Emily G McDonald, and Todd C Lee
February 2023, The New England journal of medicine,
Emily G McDonald, and Todd C Lee
June 2023, The New England journal of medicine,
Copied contents to your clipboard!